Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study

Abstract

Background Patients with inflammatory bowel disease report multiple symptoms, but the relationships among co-occurring symptoms are poorly understood. This study aimed to examine the prevalence of symptoms and explore symptom clusters and possible associations between symptom clusters and socio-demographic and clinical variables in patients newly diagnosed with inflammatory bowel disease. Methods The IBSEN III study is a prospective population-based inception cohort of patients with inflammatory bowel disease. This study used patient data from the three largest hospitals in the study catchment area. The Memorial Symptom Assessment Scale was used to assess the prevalence of symptoms. Symptom clusters were identified using principal component analysis. Possible associations between socio-demographic and clinical variables and symptom cluster membership were estimated using regression analysis. Results Of the 573 patients (age, ≥18 years) diagnosed with inflammatory bowel disease, 350 (61.1%) completed the questionnaire (responders). Eleven symptoms were reported by >50% of the responders. The three most prevalent symptoms were bloating (84%), drowsiness (81%), and lack of energy (81%). Three symptom clusters were identified: psychological (56% of the patients), impaired energy (28%), and physical (16%) clusters. Multinomial regression analysis revealed that vitamin D deficiency was significantly associated with the impaired energy cluster (odds ratio=2.49, 95% confidence interval [1.00-6.2], p=0.05). Conclusions We found high symptom prevalence in patients newly diagnosed with inflammatory bowel disease. Three distinct symptom clusters were identified, and the psychological cluster includes >50% of the patients. Vitamin D deficiency is the only factor associated with cluster membership, namely the impaired energy cluster.

Identifying central symptoms and central symptom clusters in acute myeloid leukemia patients receiving chemotherapy: A network analysis

“…Based on a previous study, to ensure su cient variation and covariation for EFA, only symptoms that occurred in more than 40% of the participants were included 24,25 . EFA with principal component analysis (PCA), which can analyze relationships among observed variables that can be explained by many latent and unobserved variables (i.e., factors), was chosen to identify SCs by severity scores.…”

What do people with inflammatory bowel disease want to know about diet? The dietary information needs of people with inflammatory bowel disease and perceptions of healthcare providers

“…IBD is a disease with considerable symptom burden, with recent results from an ongoing observational population-based cohort study reporting clusters of psychological, energy and physical symptoms rarely occurring in isolation. 6 Maintaining remission and improving gastrointestinal symptoms via medical management are important goals for the treatment and management of IBD. However, individuals can continue to experience symptoms negatively impacting their QoL.…”

Food-Related Behavioral Patterns in Patients with Inflammatory Bowel Diseases: The Role of Food Involvement and Health Engagement

“…Inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), is a lifelong incurable condition, affecting approximately 0.2% of the European population and around five million worldwide, and represents a substantial and escalating global health challenge [ 1 , 2 ]. IBD manifests with several gastrointestinal symptoms characterized by alternating periods of exacerbation and remission [ 3 ], typically emerging as pain, diarrhea, abdominal discomfort, fatigue, reduced appetite, and weight loss, impacting daily living activities and resulting in a significant decrease in health-related quality of life [ 4 ]. These symptoms are initiated and triggered by environmental factors, such as diet, in individuals genetically susceptible to the condition, characterized by gut dysbiosis and abnormal immune response [ 5 ].…”